Roy K - Search Results

1

Chimeric aptamers in cancer cell-targeted drug delivery.

Kanwar JR, Roy K, Kanwar RK. Kanwar JR, et al. Among authors: roy k. Crit Rev Biochem Mol Biol. 2011 Dec;46(6):459-77. doi: 10.3109/10409238.2011.614592. Epub 2011 Sep 28. Crit Rev Biochem Mol Biol. 2011. PMID: 21955150 Free PMC article. Review.

2

Applications of aptamers in nanodelivery systems in cancer, eye and inflammatory diseases.

Kanwar JR, Mohan RR, Kanwar RK, Roy K, Bawa R. Kanwar JR, et al. Among authors: roy k. Nanomedicine (Lond). 2010 Nov;5(9):1435-45. doi: 10.2217/nnm.10.115. Nanomedicine (Lond). 2010. PMID: 21128724 Review.

3

Nucleic acid-based aptamers: applications, development and clinical trials.

Kanwar JR, Roy K, Maremanda NG, Subramanian K, Veedu RN, Bawa R, Kanwar RK. Kanwar JR, et al. Among authors: roy k. Curr Med Chem. 2015;22(21):2539-57. doi: 10.2174/0929867322666150227144909. Curr Med Chem. 2015. PMID: 25723512 Review.

4

Comparative activities of milk components in reversing chronic colitis.

Kanwar JR, Kanwar RK, Stathopoulos S, Haggarty NW, MacGibbon AKH, Palmano KP, Roy K, Rowan A, Krissansen GW. Kanwar JR, et al. Among authors: roy k. J Dairy Sci. 2016 Apr;99(4):2488-2501. doi: 10.3168/jds.2015-10122. Epub 2016 Jan 21. J Dairy Sci. 2016. PMID: 26805965 Free article.

5

Fe-bLf nanoformulation targets survivin to kill colon cancer stem cells and maintains absorption of iron, calcium and zinc.

Kanwar JR, Mahidhara G, Roy K, Sasidharan S, Krishnakumar S, Prasad N, Sehgal R, Kanwar RK. Kanwar JR, et al. Among authors: roy k. Nanomedicine (Lond). 2015 Jan;10(1):35-55. doi: 10.2217/nnm.14.132. Epub 2014 Jul 14. Nanomedicine (Lond). 2015. PMID: 25017148 Free article.

6

Competitive inhibition of survivin using a cell-permeable recombinant protein induces cancer-specific apoptosis in colon cancer model.

Roy K, Kanwar RK, Krishnakumar S, Cheung CH, Kanwar JR. Roy K, et al. Int J Nanomedicine. 2015 Feb 2;10:1019-43. doi: 10.2147/IJN.S73916. eCollection 2015. Int J Nanomedicine. 2015. PMID: 25678789 Free PMC article.

7

Targeting VEGF with LNA-stabilized G-rich oligonucleotide for efficient breast cancer inhibition.

Edwards SL, Poongavanam V, Kanwar JR, Roy K, Hillman KM, Prasad N, Leth-Larsen R, Petersen M, Marušič M, Plavec J, Wengel J, Veedu RN. Edwards SL, et al. Among authors: roy k. Chem Commun (Camb). 2015 Jun 11;51(46):9499-502. doi: 10.1039/c5cc02756j. Epub 2015 May 13. Chem Commun (Camb). 2015. PMID: 25968110

8

Multifunctional iron bound lactoferrin and nanomedicinal approaches to enhance its bioactive functions.

Kanwar JR, Roy K, Patel Y, Zhou SF, Singh MR, Singh D, Nasir M, Sehgal R, Sehgal A, Singh RS, Garg S, Kanwar RK. Kanwar JR, et al. Among authors: roy k. Molecules. 2015 May 26;20(6):9703-31. doi: 10.3390/molecules20069703. Molecules. 2015. PMID: 26016555 Free PMC article. Review.

9

Oral administration of iron-saturated bovine lactoferrin-loaded ceramic nanocapsules for breast cancer therapy and influence on iron and calcium metabolism.

Mahidhara G, Kanwar RK, Roy K, Kanwar JR. Mahidhara G, et al. Among authors: roy k. Int J Nanomedicine. 2015 Jun 22;10:4081-98. doi: 10.2147/IJN.S75877. eCollection 2015. Int J Nanomedicine. 2015. PMID: 26124661 Free PMC article.

10

LNA aptamer based multi-modal, Fe3O4-saturated lactoferrin (Fe3O4-bLf) nanocarriers for triple positive (EpCAM, CD133, CD44) colon tumor targeting and NIR, MRI and CT imaging.

Roy K, Kanwar RK, Kanwar JR. Roy K, et al. Biomaterials. 2015 Dec;71:84-99. doi: 10.1016/j.biomaterials.2015.07.055. Epub 2015 Aug 4. Biomaterials. 2015. PMID: 26318819

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,793 results

Search Page